cmi_logo.png
[Latest] Global Cancer Cachexia Market Size/Share Worth USD 5.1 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 03, 2024 04:30 ET | Custom Market Insights
Austin, TX, USA, May 03, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Cachexia Market Size, Trends and Insights By Therapeutics (Progestogen,...
fulllogo_transparent_nobuffer Aanastra.png
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
May 02, 2024 06:30 ET | Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
cmi_logo.png
[Latest] Global Lipid Nanoparticles Market Size/Share Worth USD 1,899.8 Million by 2033 at a 14.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 02, 2024 04:30 ET | Custom Market Insights
Austin, TX< USA, May 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lipid Nanoparticles Market Size, Trends and Insights By Type (Nano-Structured...
Blank Rome Launches in Boston with Prominent 25-Attorney Corporate and Finance Team
Blank Rome Launches in Boston with Prominent 25-Attorney Corporate and Finance Team
May 01, 2024 08:44 ET | Blank Rome LLP
Boston, MA, May 01, 2024 (GLOBE NEWSWIRE) -- Blank Rome is pleased to announce that the firm has expanded its national platform with the opening of a new office in Boston, anchored by 13 partners...
RS BioTherapeutics Logo.jpg
RS BioTherapeutics Launches Crowdfunding Campaign Through StartEngine
April 30, 2024 10:00 ET | RS BioTherapeutics
RS BioTherapeutics announced today the launch of an SEC Regulation Crowdfunding (Reg CF) investment campaign through StartEngine.
NFI Group Inc-New Flyer Xcelsior CHARGE NG 40' bus, high rez
Boston orders 80 advanced zero-emission buses from NFI subsidiary New Flyer with options to purchase an additional 380 buses
April 29, 2024 07:00 ET | NFI Group Inc
Purchase of New Flyer’s zero-emission Xcelsior CHARGE NG™ buses marks a major step forward in Massachusetts Bay Transportation Authority’s effort to transition to an all-electric bus fleet ST....
Picture3.jpg
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
April 17, 2024 07:49 ET | Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery...
Global Prediabetes Market
Global Prediabetes Market Analysis Report 2024-2030, Featuring Valbiotis, RESVERLOGIX, Caelus Health, SciMar, Boston Therapeutics, Aphaia Pharma, AstraZeneca and Bristol-Myers Squibb
April 15, 2024 11:18 ET | Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones), Age Group (Children, Adult), Region,...
cmi_logo.png
[Latest] Global Pet Cancer Therapeutics Market Size/Share Worth USD 1,162.4 Million by 2033 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 08, 2024 13:30 ET | Custom Market Insights
Austin, TX, USA, April 08, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pet Cancer Therapeutics Market Size, Trends and Insights By Therapy...
fulllogo_transparent_nobuffer Aanastra.png
Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET | Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference